Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tubulin alpha-1B chain (TUBA1B) is an essential component of microtubules, which are critical cytoskeletal filaments composed of heterodimers of α- and β-tubulin[2][4][1]. This protein is highly conserved and is fundamental for cellular processes such as maintaining cell structure, supporting mitotic cell division, enabling intracellular transport, and facilitating cell motility. TUBA1B is differentially expressed in normal and tumor cells; its upregulation is commonly observed across a wide range of cancers. Functionally, TUBA1B drives tumor progression by promoting cell proliferation, migration, and invasion, and plays a pivotal role in shaping the tumor immune microenvironment by enhancing immunosuppressive features and influencing immune checkpoints. It is also involved in modulating responses to immunotherapy, affecting tumor mutation burden and immune cell infiltration. Tubulin alpha-1B is the target of several chemotherapeutic agents (microtubule-targeting agents), and alterations in its expression or structure can contribute to drug resistance and significant safety concerns such as neuropathy and haematotoxicity. TUBA1B serves as an important prognostic and predictive biomarker in oncology, and ongoing research is assessing its utility as a direct therapeutic target[1][2][3][4].
Microtubule stabilization (e.g., taxanes prevent microtubule depolymerization)\nMicrotubule destabilization/disruption (e.g., vinca alkaloids inhibit microtubule polymerization)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tubulin alpha-1B chain (TUBA1B).